Myeloid Leukemia

Myeloid Leukemia - most related articles:

- Understanding chronic myeloid leukemia - 7.6
- Gleevec improves special leukemia in children - 6.9
- Vaccine may cure chronic myeloid leukemia CML - 5.1
- Early stem cell transplant best for acute myeloid leukemia patients - 4.9
- Stem cell protein LIN28 offers a new cancer target - 4.1
- Green tea shows promise in leukemia - 4.1
- Test for targeted therapy in acute myeloid leukemia - 4
- Grape seed extract may cure leukemia - 3.7
- Hannah Jones refused heart transplant surgery - 3.6
- Chemotherapy target found for leukemia - 3.6

Myeloid Leukemia articles

Vaccine may cure chronic myeloid leukemia CML
Johns Hopkins Kimmel Cancer Center researchers say preliminary studies show that a vaccine made with leukemia cells may be able to reduce or eliminate the last remaining cancer cells in some chronic myeloid leukemia (CML) patients taking the drug Imatinib mesylate (Gleevec).

Early stem cell transplant best for acute myeloid leukemia patients
A stem cell transplant (SCT) from a compatible donor early in the course of disease is the best approach for the majority of young and middle-aged adult patients with acute myeloid leukemia (AML), according to a new analysis of two dozen clinical studies.

Test for targeted therapy in acute myeloid leukemia
An Oregon Health & Science University Cancer Institute researcher has discovered that a particular hormone is responsible for driving a cancer enzyme to cause an often deadly red blood cell cancer.

Gleevec improves special leukemia in children
Gleevec, the targeted cancer pill that has saved more than 100,000 lives, now is saving more children with a dire leukemia, as well as preventing disease progression with long term use in adults with chronic myeloid leukemia.

Understanding chronic myeloid leukemia
Oregon Health & Science University Cancer Institute researchers have opened a new window into the roots of chronic myeloid leukemia (CML). "We are looking under the surface of CML to understand better where the cancer is coming from. We have discovered abnormal cells in the early stem cell population in some CML patients, which don't belong to the CML clone. These are abnormal cells that are not part of the CML clone," said Thomas Bumm, M.D., OHSU Cancer Institute member.

5 Myeloid Leukemia articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
1.82